In human fibrosarcoma cells (HT-1080), TPL can modulate the expression and activity of both MMP-2 and MMP-9, and it can reduce invasiveness by directly lowering MMP-9 gene expression and activity [17]. This evidence concerns the gene MMP9 and fibrosarcoma.